Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ARCA Announces AB201 Development Program for COVID-19 Associated Coagulopathy

americanpharmaceuticalreviewJune 04, 2020

Tag: ARCA , AB201 , COVID-19 , coagulopathy

PharmaSources Customer Service